APFED to Kick Off 17th Annual Patient Education Conference on Eosinophil-Associated Diseases in Washington, D.C. Area (July 25-27, 2019)

July 18, 2019

washington dc

(Atlanta, GA)—The American Partnership for Eosinophilic Disorders (APFED) is pleased to announce that its 17th Annual Patient Education Conference on Eosinophil-Associated Diseases (EADs) will be held next week in the Washington, D.C. area on July 25-27. This annual event is attended by patients, caregivers, families, advocates, healthcare providers, and researchers, who all come together to learn and network in a supportive environment.

Eosinophil-associated diseases are chronic inflammatory conditions characterized by elevated levels of eosinophils (a type of white blood cell) in one or more specific areas of the body. The higher-than-normal number of eosinophils cause inflammation and damage to tissues and organs. These chronic diseases require lifelong treatment and symptoms may be debilitating.

EOS Connection 2019 will take place at the DoubleTree by Hilton in Bethesda, MD.  The conference will feature presentations from medical experts, engaging breakouts sessions, and three days of social events. A webcast of select sessions is available to “virtual” registrants.

This year’s EOS Connection conference is held in collaboration with the Center for Pediatric Eosinophilic Disorders at Children’s Hospital of Philadelphia (CHOP) and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).  Attendees from around the globe participate in APFED’s conference to learn the latest in disease diagnostic and treatment advancements, get research updates from experts in the field, and learn practical strategies to help cope with the physical and emotional challenges of living with these disorders. The conference also includes special programming for children and teens.

The three-day event will end on July 27 with a family-friendly social mixer and casino-themed fundraiser that is open to the public and will benefit eosinophil-associated disease research.

“EOS Connection is truly a special event. It is inspiring to see our patient community come together with such excitement, enthusiasm, and willingness to support one another,” said APFED Executive Director Mary Jo Strobel. “We are deeply grateful to our esteemed panel of speakers who are lending their time and expertise to teach patients, and we are excited to welcome attendees onsite for what promises to be an amazing weekend that inspires hope.”

EOS Connection 2019 is made possible thanks to the generous support of APFED’s Education Partners, including Platinum Partners Abbott, AstraZeneca, and Celgene.

Learn more about the conference and register at apfed.org.


About American Partnership for Eosinophilic Disorders (APFED)

APFED is a non-profit organization dedicated to patients and their families coping with eosinophilic disorders. APFED’s mission is to embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. apfed.org